Here's the live share price of Laurus Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Laurus Labs | 2.17 | 5.11 | 35.18 | 87.55 | 134.26 | 72.17 | 26.01 |
| Sun Pharmaceutical Industries | -2.93 | -5.97 | -9.38 | 2.30 | 5.94 | 16.08 | 16.11 |
| Divi's Laboratories | 0.34 | -1.65 | 36.92 | 56.54 | 52.09 | 36.06 | 12.63 |
| Torrent Pharmaceuticals | -2.14 | -5.51 | -4.83 | 13.85 | 31.30 | 35.10 | 24.08 |
| Zydus Lifesciences | -2.63 | -1.23 | -3.86 | 23.60 | 11.95 | 22.90 | 15.27 |
| Cipla | -3.23 | -4.73 | -9.60 | 6.46 | -13.83 | 3.97 | 7.36 |
| Dr. Reddy's Laboratories | -0.42 | 4.54 | -5.88 | -1.42 | -4.06 | 2.83 | 4.08 |
| Mankind Pharma | -6.13 | 4.69 | -6.29 | 15.49 | -4.33 | 10.24 | 10.75 |
| Aurobindo Pharma | 0.66 | -0.23 | 6.28 | 25.88 | 50.69 | 22.80 | 18.54 |
| Lupin | -3.40 | -6.31 | -21.69 | -14.64 | 0.13 | 19.47 | 15.37 |
| Glenmark Pharmaceuticals | -1.93 | -6.08 | 1.15 | 5.63 | 18.37 | 42.93 | 33.83 |
| Alkem Laboratories | 0.42 | 2.37 | -6.83 | -2.00 | -3.91 | 14.03 | 6.03 |
| Biocon | -6.04 | -11.77 | -13.66 | 0.80 | -1.20 | 10.18 | -0.65 |
| Abbott India | -3.18 | 3.00 | -2.93 | 0.70 | -12.46 | 4.20 | 3.35 |
| Gland Pharma | 6.56 | 1.23 | 24.02 | 75.38 | 56.63 | 23.65 | -4.28 |
| Anthem Biosciences | 1.13 | -8.47 | 14.96 | 19.88 | 11.77 | 5.75 | 3.41 |
| Ipca Laboratories | -1.56 | -2.73 | 7.80 | 31.74 | 42.72 | 26.85 | 10.14 |
| GlaxoSmithKline Pharmaceuticals | -8.63 | -12.17 | 3.76 | 7.40 | -8.11 | 18.00 | 11.41 |
| Ajanta Pharma | -4.89 | -3.74 | 3.08 | 23.89 | 40.69 | 25.01 | 17.29 |
| Emcure Pharmaceuticals | -5.59 | -4.19 | 1.50 | 14.55 | 31.47 | 10.53 | 6.19 |
Source: Dion Global
Over the last one year, Laurus Labs has gained 134.26% compared to peers like Sun Pharmaceutical Industries (5.94%), Divi's Laboratories (52.09%), Torrent Pharmaceuticals (31.30%). From a 5 year perspective, Laurus Labs has outperformed peers relative to Sun Pharmaceutical Industries (16.11%) and Divi's Laboratories (12.63%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,008.72 | 2,022.73 |
| 10 | 2,010.33 | 2,006.66 |
| 20 | 1,982.61 | 1,977.22 |
| 50 | 1,897.31 | 1,872.12 |
| 100 | 1,676.42 | 1,700.41 |
| 200 | 1,368.21 | 1,459.98 |
Source: Dion Global
In the latest quarter, Laurus Labs saw a drop in promoter holding to 27.49%, while DII stake decreased to 13.73%, FII holding rose to 28.00%, and public shareholding moved down to 30.79% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 90,58,297 | 3.79 | 1,734.66 | |
| 59,53,404 | 4.31 | 1,140.08 | |
| 43,98,408 | 4.03 | 842.3 | |
| 12,82,134 | 1.29 | 245.53 | |
| 12,00,000 | 3.96 | 229.8 | |
| 11,56,727 | 0.7 | 221.51 | |
| 9,89,827 | 1.98 | 189.55 | |
| 9,72,748 | 5.24 | 186.28 | |
| 7,87,661 | 2.02 | 150.84 | |
| 6,54,940 | 0.63 | 125.42 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 10, 2026, 01:29 AM IST IST | Laurus Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 06, 2026, 11:37 PM IST IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Updates on Acquisition |
| Sep 18, 2026, 11:52 PM IST IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Sep 15, 2026, 10:59 PM IST IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 10, 2026, 06:27 AM IST IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Source: Dion Global
Laurus Labs Ltd. is a Public Limited Listed company incorporated on 19/09/2005 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L24239AP2005PLC047518 and registration number is 047518. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 6089.07 Cr. and Equity Capital is Rs. 107.97 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Laurus Labs is ₹2,032.10 as on Oct 09, 2026.
The Laurus Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Laurus Labs is ₹109,796.85 Cr as on Oct 09, 2026.
Today’s highest and lowest price of Laurus Labs are ₹2,048.00 and ₹1,988.60.
The 52-week high/low is the highest and lowest price at which Laurus Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Laurus Labs is ₹2,063.95 and 52-week low of Laurus Labs is ₹843.30 as on Oct 09, 2026.
The Laurus Labs has shown returns of 1.6% over the past day, 5.11% for the past month, 35.18% over 3 months, 134.26% over 1 year, 72.17% across 3 years, and 26.01% over 5 years.
P/E ratio of and PB ratio of Laurus Labs are 100.42 and 19.39 on Oct 09, 2026. While the company gives a dividend yield of 0.10 per annum.
Source: Dion Global